Intranasal desmopressin versus blood transfusion in cirrhotic patients with coagulopathy undergoing dental extraction: a randomized controlled trial
- PMID: 20006168
- DOI: 10.1016/j.joms.2009.07.081
Intranasal desmopressin versus blood transfusion in cirrhotic patients with coagulopathy undergoing dental extraction: a randomized controlled trial
Abstract
Purpose: Cirrhotic patients waiting for liver transplantation who need dental extractions are given fresh frozen plasma and/or platelets to correct coagulopathy. This is costly and may be associated with transfusion reactions and fluid overload. We evaluated the efficacy of intranasal desmopressin as an alternative to transfusion to correct the coagulopathy of cirrhotic patients undergoing dental extraction.
Patients and methods: Cirrhotic patients with platelet counts of 30,000 to 50,000/microL and/or international normalized ratio (INR) 2.0 to 3.0 were enrolled in a prospective, controlled, randomized clinical trial. Blood transfusion (fresh frozen plasma 10 mL/kg and/or 1 unit of single donor platelets, respectively) or intranasal desmopressin (300 microg) were given before dental extraction. A standard oral and maxillofacial surgical treatment protocol was performed by the same surgeon. Patients were followed for postextraction bleeding and side-effects over the next 24 to 48 hours.
Results: No significant differences were noted between the 2 groups in gender, age, INR, platelet count, creatinine, total bilirubin, ALT, albumin, MELD score, or number of teeth removed (median 3 vs 4). The number of teeth removed ranged between 1 and 31 in the desmopressin group and 1 and 22 in the transfusion group. No patients in desmopressin group required rescue blood transfusion after extraction. One patient in the transfusion group had bleeding after the procedure and required an additional transfusion. Another patient experienced an allergic reaction at the end of transfusion, which was effectively treated with diphenhydramine. Treatment associated average costs were lower for desmopressin ($700/patient) compared with transfusion ($1,173/patient).
Conclusions: Intranasal desmopressin was as effective as blood transfusion in achieving hemostasis in cirrhotic patients with moderate coagulopathy undergoing dental extraction. Intranasal desmopressin was much more convenient, less expensive, and well tolerated.
Similar articles
-
Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy.Can J Anaesth. 2003 Jan;50(1):14-20. doi: 10.1007/BF03020180. Can J Anaesth. 2003. PMID: 12514144 Clinical Trial.
-
Desmopressin (DDAVP) for treatment of disorders of hemostasis.Prog Hemost Thromb. 1986;8:19-45. Prog Hemost Thromb. 1986. PMID: 3104987 Review.
-
Coagulation defects do not predict blood product requirements during liver transplantation.Transplantation. 2008 Apr 15;85(7):956-62. doi: 10.1097/TP.0b013e318168fcd4. Transplantation. 2008. PMID: 18408574
-
Long-term postoperative bleeding after dentoalveolar surgery in the pretransplant liver failure patient.J Oral Maxillofac Surg. 2006 Oct;64(10):1469-74. doi: 10.1016/j.joms.2006.05.044. J Oral Maxillofac Surg. 2006. PMID: 16982303
-
The use of desmopressin in open-heart surgery.Haemophilia. 2008 Jan;14 Suppl 1:40-7. doi: 10.1111/j.1365-2516.2007.01608.x. Haemophilia. 2008. PMID: 18173693 Review.
Cited by
-
Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference.Thromb Haemost. 2018 Aug;118(8):1491-1506. doi: 10.1055/s-0038-1666861. Epub 2018 Jul 30. Thromb Haemost. 2018. PMID: 30060258 Free PMC article. No abstract available.
-
Desmopressin as a hemostatic and blood sparing agent in bleeding disorders.Eur J Haematol. 2023 May;110(5):470-479. doi: 10.1111/ejh.13930. Epub 2023 Feb 12. Eur J Haematol. 2023. PMID: 36656570 Free PMC article. Review.
-
[Anesthesia with liver failure].Anaesthesist. 2016 Jan;65(1):77-94. doi: 10.1007/s00101-015-0094-7. Anaesthesist. 2016. PMID: 26727937 Review. German.
-
Thrombocytopenia and Procedural Prophylaxis in the Era of Thrombopoietin Receptor Agonists.Hepatol Commun. 2019 Sep 4;3(11):1423-1434. doi: 10.1002/hep4.1423. eCollection 2019 Nov. Hepatol Commun. 2019. PMID: 31701067 Free PMC article. Review.
-
Primary Hemostasis in Chronic Liver Disease and Cirrhosis: What Did We Learn over the Past Decade?Int J Mol Sci. 2020 May 6;21(9):3294. doi: 10.3390/ijms21093294. Int J Mol Sci. 2020. PMID: 32384725 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical